Abstract:Spontaneous intracerebral hemorrhage (ICH) is a catastrophic illness causing significant morbidity and mortality. Despite advances in surgical technique addressing primary brain injury caused by ICH, little progress has been made treating the subsequent inflammatory cascade. Pre-clinical studies have made advancements identifying components of neuroinflammation, including microglia, astrocytes, and T lymphocytes. After cerebral insult, inflammation is initially driven by the M1 microglia, secreting cytokines (e.g., interleukin-1β [IL-1β] and tumor necrosis factor-α) that are involved in the breakdown of the extracellular matrix, cellular integrity, and the blood brain barrier. Additionally, inflammatory factors recruit and induce differentiation of A1 reactive astrocytes and T helper 1 (Th1) cells, which contribute to the secretion of inflammatory cytokines, augmenting M1 polarization and potentiating inflammation. Within 7 days of ICH ictus, the M1 phenotype coverts to a M2 phenotype, key for hematoma removal, tissue healing, and overall resolution of inflammation. The secretion of anti-inflammatory cytokines (e.g., IL-4, IL-10) can drive Th2 cell differentiation. M2 polarization is maintained by the secretion of additional anti-inflammatory cytokines by the Th2 cells, suppressing M1 and Th1 phenotypes. Elucidating the timing and trigger of the anti-inflammatory phenotype may be integral in improving clinical outcomes. A challenge in current translational research is the absence of an equivalent disease animal model mirroring the patient population and comorbid pathophysiologic state. We review existing data and describe potential therapeutic targets around which we are creating a bench to bedside translational research model that better reflects the pathophysiology of ICH patients.

Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage

Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhage

The role of complement C3 in intracerebral hemorrhage-induced brain injury.

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update

Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation

Neuroprotective Therapies for Spontaneous Intracerebral Hemorrhage

The Crosstalk Between Immune Cells After Intracerebral Hemorrhage

Gap Junctions and Hemichannels Composed of Connexins and Pannexins Mediate the Secondary Brain Injury Following Intracerebral Hemorrhage

Mechanism and Therapy of Brain Edema after Intracerebral Hemorrhage.

The hallmark and crosstalk of immune cells after intracerebral hemorrhage: Immunotherapy perspectives

Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage

Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets

The role of complement in brain injury following intracerebral hemorrhage: A review

Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage

Role of Regulatory T Cells in Intracerebral Hemorrhage

An Update on Inflammation in the Acute Phase of Intracerebral Hemorrhage

Mechanisms and potential therapeutic targets for spontaneous intracerebral hemorrhage

Bioinformatic Analysis of Coexpressed Differentially Expressed Genes and Potential Targets for Intracerebral and Subarachnoid Hemorrhage

A Protective Role of Tumor Necrosis Factor Superfamily-15 in Intracerebral Hemorrhage-Induced Secondary Brain Injury

Secondary Brain Injury by Oxidative Stress After Cerebral Hemorrhage: Recent Advances